Epithalon

Also known as: Epitalon, Epithalone, AEDG peptide

Anti-Aging

Preclinical

Epithalon is a synthetic tetrapeptide that activates telomerase, the enzyme responsible for maintaining telomere length. Telomere shortening is one of the primary mechanisms of cellular aging, and Epithalon's ability to counteract this makes it one of the most studied anti-aging peptides in gerontology.

Regulatory & Approval Status

Not FDA Approved

Epithalon is not FDA-approved as a drug. While the Pharmacy Compounding Advisory Committee (PCAC) recommended it for the 503A compounding list in July 2026, no final rulemaking has been enacted to change its legal status.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.